[Evidence for thrombosis prophylaxis to high-risk patients]

MeSH terms

• Anticoagulants / adverse effects
• Anticoagulants / therapeutic use
• Enoxaparin / adverse effects
• Enoxaparin / therapeutic use
• Evidence-Based Medicine
• Fibrinolytic Agents / adverse effects
• Fibrinolytic Agents / therapeutic use
• Heparin, Low-Molecular-Weight / adverse effects
• Heparin, Low-Molecular-Weight / therapeutic use
• Humans
• Thromboembolism / prevention & control*
• Venous Thrombosis / prevention & control*